Knee osteoarthritis injection study halted early
NCT ID NCT04931667
First seen Apr 09, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This study tested an experimental drug called lorecivivint, given as a shot into the knee, to see if it safely eases pain and improves function in people with knee osteoarthritis. The study planned to follow 72 adults aged 40 to 80 for up to 3 years, but it was stopped early. The main goal was to measure changes in knee pain using a 0-to-10 scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS OF THE KNEE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Tucson, Arizona, 85712, United States
-
Research Site
Winter Park, Florida, 32789, United States
-
Research Site
Oak Brook, Illinois, 60523, United States
-
Research Site
Dallas, Texas, 75231, United States
Conditions
Explore the condition pages connected to this study.